Silo Pharma, Inc. — Director's Dealing 2021

May 17, 2021

SEC Form 4/A — Form 4/A

Issuer: Silo Pharma, Inc. (SILO)
CIK: 0001514183
Period of Report: 2020-04-28

Reporting Person: Weisblum Eric (Director, CEO, CFO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-28	Common Stock	A	7630949	—	Acquired	7689063	Direct

Footnotes

F1: Issued to the Reporting Person pursuant to that certain Employment Agreement, dated April 17, 2020, by and between the Issuer and the Reporting Person.

F2: This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on April 30, 2020, which erroneously included the Reporting Person's stock options in Column 5 of Table I.